Managing end-of-life symptomsFor patients nearing death, palliative care can enhance quality of life by easing pain and other symptoms, improving sleep, and reducing fatigue. Managing end-of-life…
FDA approves Perjeta for late-stage breast cancerOn June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
FDA approves Votrient for advanced soft tissue sarcomaOn April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously…
Putting evidence into practice: PainThe latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Polypectomy lowers colorectal cancer mortalityA study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who had adenomatous…
Putting evidence into practice: Chemotherapy-induced peripheral neuropathyThis year continues our series from the Oncology Nursing Society on managing cancer-related symptoms.
Are you ready to care for patients in clinical trials?Part 1 of a four-part series on clinical trials
Putting evidence into practice: Prevention of infection in patients receiving cancer treatmentsLearn how you can help reduce the risk of infections in patients receiving treatment for cancer
Cancer survival remains higher in married compared to unmarriedA study, published by BMC Public Health, that examined data from 1970-2007 has found that the excess mortality of never-married compared to married people…
Evidence-based practice in healthcare: Is it on shaky ground?“Federal panel recommends against prostate cancer screening.” This news headline may have given some nurses a sense of déjà vu, and not for the…
Evidence-based interventions for chemotherapy-induced nausea and vomitingLearn what you can do to manage this devastating effect of cancer treatment.
FDA adds to boxed warning for tumor necrosis factor-alpha blockersThe U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and…
Managing end-of-life symptomsFor patients nearing death, palliative care can enhance quality of life by easing pain and other symptoms, improving sleep, and reducing fatigue.…
FDA approves Perjeta for late-stage breast cancerOn June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive…
FDA approves Votrient for advanced soft tissue sarcomaOn April 26, the U.S. Food and Drug Administration (FDA) approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who…
Putting evidence into practice: PainThe latest in a series of articles on managing cancer-related symptoms from the Oncology Nursing Society.
Polypectomy lowers colorectal cancer mortalityA study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who…
Putting evidence into practice: Chemotherapy-induced peripheral neuropathyThis year continues our series from the Oncology Nursing Society on managing cancer-related symptoms.
Are you ready to care for patients in clinical trials?Part 1 of a four-part series on clinical trials
Putting evidence into practice: Prevention of infection in patients receiving cancer treatmentsLearn how you can help reduce the risk of infections in patients receiving treatment for cancer
Cancer survival remains higher in married compared to unmarriedA study, published by BMC Public Health, that examined data from 1970-2007 has found that the excess mortality of never-married compared to…
Evidence-based practice in healthcare: Is it on shaky ground?“Federal panel recommends against prostate cancer screening.” This news headline may have given some nurses a sense of déjà vu, and not…
Evidence-based interventions for chemotherapy-induced nausea and vomitingLearn what you can do to manage this devastating effect of cancer treatment.
FDA adds to boxed warning for tumor necrosis factor-alpha blockersThe U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from…
